| Trial Status | All trial activities ended |
| Dates | Date of activation: 12-Mar-01 Closed on : 04-Apr-03 |
| Data management at EORTC | Full |
| Phase | 3 |
| Randomized trial | Yes |
| Type | Adjuvant |
| Targeted Sample size | 762 |
| Number of steps | 1 |
| Drug | Recombinant human erythropoietin alfa Recombinant human erythropoietin alfa |
| Study Staff | |
| Type of cancer | Head and Neck |
| Participating Groups | |
| Protocol summary | Cancer.gov (PDQ) ClinicalTrials.gov |
| NCT number | NCT00017277 |
| EudraCT |